We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+31.13%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$3.89B
AUM Growth
+$2.3B
Cap. Flow
+$1.81B
Cap. Flow %
46.45%
Top 10 Hldgs %
13.13%
Holding
1,688
New
594
Increased
357
Reduced
244
Closed
486

Sector Composition

Rank Sector Weight
1 Technology 19.6%
2 Consumer Discretionary 13.23%
3 Financials 10.89%
4 Industrials 10.19%
5 Healthcare 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACM icon
551
Aecom
ACM
$9.63B
$1.23M 0.03%
32,759
+22,159
+209% +$794K
NKTR icon
552
Nektar Therapeutics
NKTR
$2.48B
$1.23M 0.03%
+3,534
New +$1.1M
ATH
553
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$1.23M 0.03%
39,381
-67,419
-63% -$1.88M
MAN icon
554
ManpowerGroup
MAN
$2.54B
$1.23M 0.03%
+17,831
New +$1.22M
WRI
555
DELISTED
Weingarten Realty Investors
WRI
$1.22M 0.03%
+64,213
New +$1.12M
STE icon
556
Steris
STE
$22.3B
$1.21M 0.03%
7,853
+1,342
+21% +$204K
LMT icon
557
Lockheed Martin
LMT
$134B
$1.2M 0.03%
+3,293
New +$1.24M
SAM icon
558
Boston Beer
SAM
$1.91B
$1.2M 0.03%
+2,241
New +$1.09M
FLG
559
Flagstar Bank National Association
FLG
$5.99B
$1.2M 0.03%
39,176
+24,300
+163% +$731K
CSGP icon
560
CoStar Group
CSGP
$12.3B
$1.2M 0.03%
+16,840
New +$1.09M
AWR icon
561
American States Water
AWR
$3.31B
$1.2M 0.03%
+15,225
New +$1.21M
ONC
562
BeOne Medicines Ltd
ONC
$34.2B
$1.19M 0.03%
+6,339
New +$1.03M
IOVA icon
563
Iovance Biotherapeutics
IOVA
$2B
$1.19M 0.03%
43,359
+31,224
+257% +$1.03M
AEO icon
564
American Eagle Outfitters
AEO
$3.01B
$1.19M 0.03%
+108,800
New +$1.03M
BMRN icon
565
BioMarin Pharmaceuticals
BMRN
$11.6B
$1.17M 0.03%
9,488
+3,138
+49% +$312K
ADVM
566
DELISTED
Adverum Biotechnologies
ADVM
$1.17M 0.03%
5,600
+4,406
+369% +$780K
CMCSA icon
567
CALL
Comcast
CMCSA
$87.3B
$1.17M 0.03%
+30,000
New +$1.14M
ROP icon
568
Roper Technologies
ROP
$39B
$1.16M 0.03%
+2,995
New +$1.07M
MRSN
569
DELISTED
Mersana Therapeutics
MRSN
$1.16M 0.03%
1,977
+357
+22% +$122K
GNTX icon
570
Gentex
GNTX
$5.13B
$1.15M 0.03%
44,803
+33,803
+307% +$847K
LDOS icon
571
Leidos
LDOS
$16.1B
$1.14M 0.03%
12,156
-25,824
-68% -$2.54M
KC
572
Kingsoft Cloud Holdings
KC
$3.72B
$1.13M 0.03%
+35,882
New +$823K
ZBH icon
573
Zimmer Biomet
ZBH
$18.9B
$1.13M 0.03%
9,756
-6,091
-38% -$702K
OPTU
574
CALL
Optimum Communications Inc
OPTU
$314M
$1.13M 0.03%
+50,000
New +$1.23M
LSXMA
575
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$1.13M 0.03%
44,369
+34,239
+338% +$837K

Similar funds

Schonfeld Strategic Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Schonfeld Strategic Advisors held 1,688 positions worth $3.89B, up 145% from $1.59B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $1.81B of net new capital in Q2 2020, opening 594 new positions and adding to 357 existing holdings. Its largest new stake was Claritev Corp: 75,000 shares worth $32.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JD.com, an estimated $29.9M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2020 buy was Claritev Corp: 75,000 shares worth $32.4M.
  • Schonfeld Strategic Advisors added most to TC Energy in Q2 2020, an estimated $113M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2020 reduction was JD.com, cutting an estimated $29.9M.
  • Schonfeld Strategic Advisors fully exited Allergan plc in Q2 2020, selling an estimated $37M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $3.89B portfolio in Q2 2020.
  • Schonfeld Strategic Advisors opened 594 new positions and closed 486 in Q2 2020.
  • Schonfeld Strategic Advisors's portfolio value rose 145% quarter-over-quarter to $3.89B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.